ClinicalTrials.Veeva

Menu

Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population (Post-Covid)

L

Lithuanian University of Health Sciences

Status

Unknown

Conditions

Post-Covid Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT05000229
001/Version 1

Details and patient eligibility

About

The aim of the study is to describe the post-covid-19 syndrome in Lithuanian population regarding the remaining symptoms and their impact on physical functioning, work ability and needs of rehabilitation.

Full description

Participants with suspected and confirmed cases of COVID-19 infection will complete an anonymous online questionnaire for post-covid syndrome, i.e. symptoms lasting longer than 28 days after post-covid-19 syndrome. The online survey is developed to assess the health state before infection and residual symptoms lasting longer than acute COVID-19 infection, influencing the functional activity and work ability. The needs of rehabilitation will also be assessed.

Enrollment

5,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • older than 18 years age patients;
  • a history of COVID-19 infection that was and was not positive for SARS-CoV-2 diagnostic or antibody testing
  • the duration of remaining symptoms is longer than 28 days
  • ability to fulfil internet-based questionnaire

Exclusion criteria

  • ongoing covid-19 infection
  • other comorbidities requiring treatment or rehabilitation

Trial contacts and locations

1

Loading...

Central trial contact

Dovilė Važgėlienė

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems